Go Pro

Crescent Biopharma (CBIO) Institutional Ownership

Crescent Biopharma logo
$20.88 +0.48 (+2.35%)
As of 09/4/2026 04:00 PM Eastern

Institutional Ownership Changes (13F Filings) for Crescent Biopharma (NASDAQ:CBIO)

Current
Institutional Ownership
Percentage
75.19%
Number of
Institutional Buyers
(last 12 months)
37
Total
Institutional Inflows
(last 12 months)
$145.98M
Number of
Institutional Sellers
(last 12 months)
9
Total
Institutional Outflows
(last 12 months)
$16.65M
Get CBIO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Crescent Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

CBIO Institutional Buying and Selling by Quarter

Crescent Biopharma Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/24/2026 California State Teachers Retirement System5,346$96K0.0%N/A0.014%
8/19/2026 Wellington Management Group LLP14,600$263K0.0%N/A0.039%
8/18/2026 Stonepine Capital Management LLC40,000$720K0.0%N/A0.108%
8/17/2026 Bank of America Corp DE25,821$465K0.0%N/A0.070%
8/14/2026 ADAR1 Capital Management LLC18,275$329K0.0%N/A0.049%
8/14/2026 Legal & General Group Plc2,097$38K0.0%N/A0.006%
8/14/2026 The Manufacturers Life Insurance Company 17,755$320K0.0%N/A0.048%
8/7/2026 BlackRock Inc.1,271,762$22.89M0.0%N/A4.615%
8/7/2026 Persistent Asset Partners Ltd10,968$197K0.1%N/A0.040%
8/6/2026 Bank of New York Mellon Corp45,778$824K0.0%N/A0.166%
5/29/2026 Perceptive Advisors LLC206,942$3.80M0.1%-54.4%0.751%
5/19/2026 Bank of America Corp DE29,277$538K0.0%+425.3%0.106%
5/18/2026 ADAR1 Capital Management LLC50,273$924K0.1%-91.7%0.182%
5/18/2026 Exome Asset Management LLC153,191$2.81M1.5%N/A0.556%
5/15/2026 OMERS ADMINISTRATION Corp17,800$327K0.0%+53.4%0.065%
5/14/2026 Renaissance Technologies LLC24,262$446K0.0%-48.0%0.088%
5/6/2026 Jennison Associates LLC152,974$2.81M0.0%N/A0.555%
4/21/2026 Cannon Global Investment Management LLC10,200$187K0.4%N/A0.073%
2/18/2026 ADAR1 Capital Management LLC606,000$7.19M0.5%N/A4.362%
2/18/2026 Vestal Point Capital LP1,500,000$17.79M0.6%N/A10.797%
2/18/2026 Tang Capital Management LLC872,398$10.35M0.5%+28.3%6.279%
2/18/2026 Quadrature Capital Ltd13,246$157K0.0%N/A0.095%
2/18/2026 RTW Investments LP372,856$4.42M0.0%N/A2.684%
2/18/2026 Opaleye Management Inc.1,178,300$13.98M1.8%N/A8.483%
2/18/2026 Millennium Management LLC61,882$734K0.0%N/A0.446%
2/18/2026 Moore Capital Management LP25,000$296K0.0%N/A0.180%
2/18/2026 Balyasny Asset Management L.P.111,715$1.33M0.0%N/A0.804%
2/18/2026 BVF Inc. IL2,748,763$32.60M1.1%+98.1%19.790%
2/17/2026 ADAR1 Capital Management LLC606,000$7.19M0.5%N/A4.363%
2/17/2026 Burkehill Global Management LP74,000$844K0.1%N/A0.533%
2/17/2026 Heights Capital Management Inc.264,000$3.13M1.1%N/A1.901%
2/17/2026 Price T Rowe Associates Inc. MD338,125$4.01M0.0%-11.9%2.434%
2/17/2026 Fcpm Iii Services B.V.1,677,852$19.90M2.6%N/A12.080%
2/16/2026 OMERS ADMINISTRATION Corp11,600$138K0.0%N/A0.084%
2/16/2026 NEXTBio Capital Management LP372,856$4.42M2.6%N/A2.684%
2/13/2026 Marshall Wace LLP21,826$259K0.0%-50.0%0.157%
2/13/2026 Alyeska Investment Group L.P.264,000$3.11M0.0%N/A1.901%
2/13/2026 State Street Corp26,217$311K0.0%+40.8%0.189%
2/12/2026 Jane Street Group LLC22,965$272K0.0%N/A0.165%
2/12/2026 HRT Financial LP13,083$155K0.0%N/A0.094%
MILLIONAIRE MASTERCLASS INVITE: Altucher (Ad)

James Altucher says Elon Musk is preparing an unprecedented project set to surface on September 25. Altucher is hosting a free masterclass revealing what he says is locked inside a sealed briefcase detailing Musk's plans. Attendees who join early can also access a $1,000 bonus offer included with the presentation.tc pixel

Watch James Altucher's free masterclass before September 25
2/12/2026 Renaissance Technologies LLC46,700$554K0.0%+73.6%0.336%
2/10/2026 Goldman Sachs Group Inc.25,245$299K0.0%-31.7%0.182%
2/9/2026 Geode Capital Management LLC91,079$1.08M0.0%+31.7%0.656%
2/9/2026Jefferies Financial Group Inc.64,244$762K0.0%-37.5%0.462%
11/17/2025 Citadel Advisors LLC25,593$304K0.0%N/A0.184%
11/17/2025 Commodore Capital LP450,829$5.36M0.3%-0.6%3.245%
11/17/2025 Bank of America Corp DE3,863$46K0.0%-58.2%0.028%
11/14/2025 Two Sigma Investments LP28,318$337K0.0%N/A0.204%
11/13/2025Jefferies Financial Group Inc.102,714$1.22M0.0%+279.1%0.739%
11/7/2025Vanguard Group Inc.657,900$7.82M0.0%N/A3.365%
8/15/2025 Soleus Capital Management L.P.400,000$6.46M0.4%N/A2.046%
8/15/2025 Perceptive Advisors LLC453,686$7.32M0.7%N/A2.321%
8/15/2025 Frazier Life Sciences Management L.P.453,685$7.32M0.3%N/A2.321%
8/15/2025 Braidwell LP261,504$4.22M0.1%N/A1.338%
8/15/2025 BVF Inc. IL1,387,863$22.40M0.8%N/A7.099%
8/15/2025 Bank of America Corp DE9,231$149K0.0%N/A0.047%
8/15/2025 Adage Capital Partners GP L.L.C.100,912$1.63M0.0%N/A0.516%
8/14/2025 Commodore Capital LP453,686$7.32M0.5%N/A2.321%
8/13/2025 Affinity Asset Advisors LLC280,031$4.52M0.6%N/A1.432%
8/12/2025Jefferies Financial Group Inc.27,096$437K0.0%N/A0.139%
8/7/2023Acadian Asset Management LLC144,028$50K0.0%-44.5%0.381%
2/15/2023Nantahala Capital Management LLC438,055$231K0.0%-82.9%1.392%
11/10/2022Nantahala Capital Management LLC2,554,735$1.29M0.1%-7.3%8.116%
11/7/2022Virtu Financial LLC189,175$95K0.0%+250.5%0.601%
8/15/2022Nantahala Capital Management LLC2,755,903$4.91M0.2%+13.8%8.755%
8/13/2022Virtu Financial LLC53,977$96K0.0%N/A0.171%


CBIO Institutional Ownership - Frequently Asked Questions

During the previous two years, 47 institutional investors and hedge funds held shares of Crescent Biopharma. The most heavily invested institutionals were BVF Inc. IL ($32.60M), BlackRock Inc. ($22.89M), Fcpm Iii Services B.V. ($19.90M), Vestal Point Capital LP ($17.79M), Opaleye Management Inc. ($13.98M), Tang Capital Management LLC ($10.35M), and Vanguard Group Inc. ($7.82M).Learn more on Crescent Biopharma's institutional investors.

75.19% of Crescent Biopharma's stock is owned by institutional investors. Learn more on CBIO's institutional investor holdings.

Of the 44 institutional investors that purchased Crescent Biopharma's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BVF Inc. IL ($2.75M), Fcpm Iii Services B.V. ($1.68M), Vestal Point Capital LP ($1.50M), BlackRock Inc. ($1.27M), ADAR1 Capital Management LLC ($1.23M), Opaleye Management Inc. ($1.18M), and Vanguard Group Inc. ($657.90K).

Institutional investors have bought a total of 11,364,274 shares in the last 24 months. This purchase volume represents approximately $145.98M in transactions.

Of the 9 institutional investors that sold Crescent Biopharma's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: ADAR1 Capital Management LLC ($555.73K), Perceptive Advisors LLC ($246.74K), Price T Rowe Associates Inc. MD ($45.47K), Jefferies Financial Group Inc. ($38.47K), Renaissance Technologies LLC ($22.44K), Marshall Wace LLP ($21.87K), and Goldman Sachs Group Inc. ($11.73K).

Institutional investors have sold a total of 950,672 shares in the last 24 months. This volume of shares sold represents approximately $16.65M in transactions.



Institutional ownership data for NASDAQ:CBIO is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 8/24/2026. New 13F filings are added each quarter as they're published.
From Our Partners